Avepoint Inc. Financials
This page shows Avepoint Inc. (AVPT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High-margin software revenue and tiny capital needs let AvePoint’s cash engine mature before reported earnings did.
FY2024 already looked economically profitable even before GAAP earnings caught up: a-$29.1M net loss still produced$85.9M of free cash flow. When FY2025 net income turned positive at$34.8M and free cash flow stayed at$81.6M , it showed the cash conversion engine was established before the income statement fully reflected it.
The most important margin pattern is that gross margin stayed around
FY2025 ended with
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Avepoint Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Avepoint Inc. has an operating margin of 7.9%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 41/100, indicating healthy but not exceptional operating efficiency. This is up from 2.2% the prior year.
Avepoint Inc.'s revenue surged 26.9% year-over-year to $419.5M, reflecting rapid business expansion. This strong growth earns a score of 85/100.
Avepoint Inc. has a moderate D/E ratio of 0.65. This balance of debt and equity financing earns a leverage score of 55/100.
Avepoint Inc.'s current ratio of 2.28 indicates adequate short-term liquidity, earning a score of 64/100. The company can meet its near-term obligations, though with limited headroom.
Avepoint Inc. converts 19.4% of revenue into free cash flow ($81.6M). This strong cash generation earns a score of 87/100.
Avepoint Inc.'s ROE of 7.3% shows moderate profitability relative to equity, earning a score of 37/100. This is up from -10.7% the prior year.
Avepoint Inc. scores 5.55, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.7B) relative to total liabilities ($310.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Avepoint Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Avepoint Inc. generates $2.45 in operating cash flow ($85.3M OCF vs $34.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Avepoint Inc. earns $7.2 in operating income for every $1 of interest expense ($33.0M vs $4.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Avepoint Inc. generated $419.5M in revenue in fiscal year 2025. This represents an increase of 26.9% from the prior year.
Avepoint Inc.'s EBITDA was $36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 258.0% from the prior year.
Avepoint Inc. reported $34.8M in net income in fiscal year 2025. This represents an increase of 219.6% from the prior year.
Avepoint Inc. earned $0.15 per diluted share (EPS) in fiscal year 2025. This represents an increase of 193.8% from the prior year.
Cash & Balance Sheet
Avepoint Inc. generated $81.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 5.0% from the prior year.
Avepoint Inc. held $481.1M in cash against $0 in long-term debt as of fiscal year 2025.
Avepoint Inc. had 215M shares outstanding in fiscal year 2025. This represents an increase of 10.8% from the prior year.
Margins & Returns
Avepoint Inc.'s gross margin was 74.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the prior year.
Avepoint Inc.'s operating margin was 7.9% in fiscal year 2025, reflecting core business profitability. This is up 5.7 percentage points from the prior year.
Avepoint Inc.'s net profit margin was 8.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 17.1 percentage points from the prior year.
Avepoint Inc.'s ROE was 7.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 18.0 percentage points from the prior year.
Capital Allocation
Avepoint Inc. invested $52.6M in research and development in fiscal year 2025. This represents an increase of 8.0% from the prior year.
Avepoint Inc. spent $49.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 50.5% from the prior year.
Avepoint Inc. invested $3.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 21.0% from the prior year.
AVPT Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $117.2M+2.2% | $114.7M+4.5% | $109.7M+7.6% | $102.0M+9.6% | $93.1M+4.4% | $89.2M+0.4% | $88.8M+13.9% | $78.0M |
| Cost of Revenue | $31.9M+5.3% | $30.3M+7.6% | $28.1M+6.3% | $26.5M+10.8% | $23.9M+9.0% | $21.9M+3.3% | $21.2M+12.0% | $18.9M |
| Gross Profit | $85.4M+1.1% | $84.4M+3.5% | $81.6M+8.0% | $75.5M+9.2% | $69.2M+2.8% | $67.3M-0.5% | $67.6M+14.5% | $59.0M |
| R&D Expenses | $13.8M+5.8% | $13.0M-6.7% | $13.9M+7.5% | $13.0M+2.1% | $12.7M-1.4% | $12.9M+0.3% | $12.8M+2.7% | $12.5M |
| SG&A Expenses | $16.9M-10.0% | $18.7M-21.6% | $23.9M+21.4% | $19.7M+5.6% | $18.7M+9.0% | $17.1M+0.5% | $17.0M-6.3% | $18.2M |
| Operating Income | $12.7M-12.4% | $14.5M+78.7% | $8.1M+14.6% | $7.1M+115.8% | $3.3M-32.3% | $4.9M-36.6% | $7.7M+457.9% | -$2.1M |
| Interest Expense | $252K-77.3% | $1.1M-53.4% | $2.4M+74.0% | $1.4M+558.5% | -$299K-698.0% | $50K+11.1% | $45K+21.6% | $37K |
| Income Tax | $1.3M+298.5% | $323K+253.8% | -$210K-105.3% | $4.0M+203.1% | $1.3M+191.6% | -$1.4M-879.8% | $183K-95.2% | $3.8M |
| Net Income | $15.3M-1.3% | $15.4M+18.7% | $13.0M+349.9% | $2.9M-15.9% | $3.4M+120.5% | -$16.8M-741.9% | $2.6M+120.3% | -$12.9M |
| EPS (Diluted) | $0.07 | N/A | $0.06+500.0% | $0.01-50.0% | $0.02 | N/A | $0.01+114.3% | $-0.07 |
AVPT Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $734.2M-7.0% | $789.2M+6.1% | $743.5M+6.2% | $700.1M+16.9% | $598.8M+15.4% | $519.1M+12.1% | $463.0M+8.4% | $427.3M |
| Current Assets | $562.2M-10.1% | $625.3M+7.7% | $580.7M+7.6% | $539.8M+20.9% | $446.6M+13.1% | $394.8M+15.8% | $341.0M+7.6% | $316.9M |
| Cash & Equivalents | $444.1M-7.7% | $481.1M+2.0% | $471.6M+9.7% | $429.8M+22.3% | $351.5M+20.9% | $290.7M+16.4% | $249.8M+10.0% | $227.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $100.4M-19.4% | $124.5M+37.0% | $90.9M-2.6% | $93.3M+16.5% | $80.1M-8.3% | $87.4M+9.2% | $80.0M+2.0% | $78.4M |
| Goodwill | $37.2M-2.1% | $38.0M+0.2% | $37.9M-2.3% | $38.8M+5.6% | $36.8M+107.6% | $17.7M-6.8% | $19.0M+2.8% | $18.5M |
| Total Liabilities | $295.4M-4.9% | $310.5M+12.2% | $276.7M+7.7% | $257.0M+8.3% | $237.4M-4.3% | $248.1M+0.4% | $247.2M+12.5% | $219.9M |
| Current Liabilities | $260.3M-4.9% | $273.7M+11.8% | $244.9M+7.3% | $228.2M+9.6% | $208.2M-6.6% | $223.0M+14.5% | $194.7M+12.7% | $172.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $438.8M-8.3% | $478.7M+2.5% | $466.8M+5.3% | $443.1M+22.6% | $361.5M+33.4% | $270.9M+25.6% | $215.7M+4.0% | $207.4M |
| Retained Earnings | -$531.3M-4.2% | -$510.1M+0.2% | -$510.9M+1.4% | -$517.9M-0.5% | -$515.5M-1.0% | -$510.4M-5.4% | -$484.5M+0.2% | -$485.3M |
AVPT Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24.3M-18.2% | $29.7M-14.9% | $34.8M+71.8% | $20.3M+3994.9% | $495K-98.5% | $32.8M+1.7% | $32.2M+99.4% | $16.2M |
| Capital Expenditures | $1.3M+83.2% | $697K+37.5% | $507K-47.5% | $965K-36.3% | $1.5M+104.3% | $741K-47.3% | $1.4M+257.1% | $394K |
| Free Cash Flow | $23.0M-20.6% | $29.0M-15.6% | $34.3M+77.8% | $19.3M+1994.5% | -$1.0M-103.2% | $32.0M+3.9% | $30.8M+95.5% | $15.8M |
| Investing Cash Flow | -$1.6M-114.6% | $11.0M+1382.3% | -$857K+93.6% | -$13.5M+20.1% | -$16.9M-1268.4% | -$1.2M-201.1% | $1.2M+216.6% | -$1.0M |
| Financing Cash Flow | -$58.9M-87.1% | -$31.5M-463.3% | $8.7M-87.7% | $70.6M-7.3% | $76.2M+500.7% | $12.7M+202.3% | -$12.4M-333.6% | -$2.9M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $59.8M+166.5% | $22.4M+168.6% | $8.4M+18.5% | $7.0M-40.8% | $11.9M+4.9% | $11.3M+344.5% | $2.6M-52.8% | $5.4M |
AVPT Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.8%-0.8pp | 73.6%-0.8pp | 74.4%+0.3pp | 74.0%-0.3pp | 74.3%-1.1pp | 75.4%-0.7pp | 76.1%+0.4pp | 75.7% |
| Operating Margin | 10.9%-1.8pp | 12.7%+5.2pp | 7.4%+0.5pp | 7.0%+3.4pp | 3.5%-1.9pp | 5.4%-3.2pp | 8.6%+11.4pp | -2.7% |
| Net Margin | 13.0%-0.5pp | 13.5%+1.6pp | 11.9%+9.0pp | 2.8%-0.9pp | 3.7%+22.6pp | -18.9%-21.8pp | 2.9%+19.6pp | -16.6% |
| Return on Equity | 3.5%+0.2pp | 3.2%+0.4pp | 2.8%+2.1pp | 0.7%-0.3pp | 0.9%+7.2pp | -6.2%-7.4pp | 1.2%+7.4pp | -6.2% |
| Return on Assets | 2.1%+0.1pp | 2.0%+0.2pp | 1.8%+1.3pp | 0.4%-0.2pp | 0.6%+3.8pp | -3.2%-3.8pp | 0.6%+3.6pp | -3.0% |
| Current Ratio | 2.16-0.1 | 2.28-0.1 | 2.370.0 | 2.37+0.2 | 2.15+0.4 | 1.77+0.0 | 1.75-0.1 | 1.83 |
| Debt-to-Equity | 0.67+0.0 | 0.65+0.1 | 0.59+0.0 | 0.58-0.1 | 0.66-0.3 | 0.92-0.2 | 1.15+0.1 | 1.06 |
| FCF Margin | 19.6%-5.6pp | 25.3%-6.0pp | 31.3%+12.4pp | 18.9%+20.0pp | -1.1%-37.0pp | 35.9%+1.2pp | 34.7%+14.5pp | 20.2% |
Similar Companies
Frequently Asked Questions
What is Avepoint Inc.'s annual revenue?
Avepoint Inc. (AVPT) reported $419.5M in total revenue for fiscal year 2025. This represents a 26.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Avepoint Inc.'s revenue growing?
Avepoint Inc. (AVPT) revenue grew by 26.9% year-over-year, from $330.5M to $419.5M in fiscal year 2025.
Is Avepoint Inc. profitable?
Yes, Avepoint Inc. (AVPT) reported a net income of $34.8M in fiscal year 2025, with a net profit margin of 8.3%.
What is Avepoint Inc.'s EBITDA?
Avepoint Inc. (AVPT) had EBITDA of $36.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Avepoint Inc.'s gross margin?
Avepoint Inc. (AVPT) had a gross margin of 74.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Avepoint Inc.'s operating margin?
Avepoint Inc. (AVPT) had an operating margin of 7.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Avepoint Inc.'s net profit margin?
Avepoint Inc. (AVPT) had a net profit margin of 8.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Avepoint Inc.'s return on equity (ROE)?
Avepoint Inc. (AVPT) has a return on equity of 7.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Avepoint Inc.'s free cash flow?
Avepoint Inc. (AVPT) generated $81.6M in free cash flow during fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Avepoint Inc.'s operating cash flow?
Avepoint Inc. (AVPT) generated $85.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Avepoint Inc.'s total assets?
Avepoint Inc. (AVPT) had $789.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Avepoint Inc.'s capital expenditures?
Avepoint Inc. (AVPT) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Avepoint Inc. spend on research and development?
Avepoint Inc. (AVPT) invested $52.6M in research and development during fiscal year 2025.
What is Avepoint Inc.'s current ratio?
Avepoint Inc. (AVPT) had a current ratio of 2.28 as of fiscal year 2025, which is generally considered healthy.
What is Avepoint Inc.'s debt-to-equity ratio?
Avepoint Inc. (AVPT) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Avepoint Inc.'s return on assets (ROA)?
Avepoint Inc. (AVPT) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Avepoint Inc.'s Altman Z-Score?
Avepoint Inc. (AVPT) has an Altman Z-Score of 5.55, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Avepoint Inc.'s Piotroski F-Score?
Avepoint Inc. (AVPT) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Avepoint Inc.'s earnings high quality?
Avepoint Inc. (AVPT) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Avepoint Inc. cover its interest payments?
Avepoint Inc. (AVPT) has an interest coverage ratio of 7.2x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Avepoint Inc.?
Avepoint Inc. (AVPT) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.